姓名：王小宇

职称：副教授

主要介绍内容：

王小宇，1994年生，山东烟台人，副教授，硕士生导师，青岛大学特聘教授。2017年本科毕业于江南大学，同年进入天津大学硕博连读，2023年6月获得天津大学工学博士学位，2023年8月加入青岛大学材料科学与工程学院生化工程研究院。以第一作者/共同第一作者在 ACS Nano，Chemical Engineering Journal，Journal of Nanobiotechnology，Applied Materials Today，ACS Applied Materials & Interface等主流期刊发表论文10余篇。

联系方式：

办公室：青岛大学慎思楼413

Email: wangxiaoyuly@163.com

主要研究方向：

（1）     基因/药物的智能纳米递送系统的设计与应用；

（2）     生物材料在组织工程和再生医学中的研究。

本人与天津大学、福建医科大学附属第一医院、青岛市中心医院、武警某单位等具有广泛深入合作，科研表现优异的同学可获得推荐联合培养与读博机会。除了致力于培养学生科研能力之外，也会根据学生的兴趣和发展需求，提供个性化的学术和职业规划指导。诚挚欢迎对科研有兴趣和理想的同学加入，未来共同努力！

部分代表性论文：

（1）X. Wang#, B. Gao#, M. Wang, Q. Wang, S. Xia, W. Zhang, X. Meng, Y. Feng*, CO delivery nanosystem based on regenerative bioactive zinc MOFs highlights intercellular crosstalk for enhanced vascular remodeling in CLI therapy. Chemical Engineering Journal, 2023,452: 139670.

（2）X. Wang#, B. Gao#, G. S. A. Suleiman, X.K. Ren, J. Guo, S.i X., W. Zhang, Y. Feng*, A “controlled CO release” and “pro-angiogenic gene” dually engineered stimulus-responsive nanoplatform for collaborative ischemia therapy. Chemical Engineering Journal, 2021, 424: 130430.

（3）B. Gao#, X. Wang#, M. Wang, K. You, G.S.A. Suleiman, X.-K. Ren, J. Guo, S. Xia, W. Zhang, Y. Feng*, Superlow Dosage of intrinsically bioactive zinc metal-organic frameworks to modulate endothelial cell morphogenesis and significantly rescue ischemic disease. ACS Nano, 2022, 16(1): 1395-1408.

（4）X. Wang, B. Gao, S. Xia, W. Zhang, X. Chen, Z. Li, X. Meng, Y. Feng*, Surface-functionalized Zinc MOFs delivering zinc ion and hydrogen sulfide as tailored anti-hindlimb ischemic nanomedicine, Applied Materials Today 32 (2023): 101843.

（5）Y. Zhang ^#, X. Wang^#, X. Niu, H. Wang, Y. Wu, C. Li, H. Wang, S. Lin, D. Wang, F. Lin, P. Yao, Y. Lin, D. Kang^*, B. Gao^*, Multi-therapeutic-activity selenium nanodot toward preventing brain injury and restoring neurobehavioral functions following hemorrhagic stroke, Journal of Nanobiotechnology, 2024, 22(1): 564.

（6）B. Gao#, X. Wang#, M. Wang, X.-K. Ren, J. Guo, S. Xia, W. Zhang, Y. Feng*, “Green process” inspires gene delivery: Establishing positive feedback between CO2-enhanced bioactive carrier and gene expression to maximize ECs outputs for multi-pathways CLI therapy. Chemical Engineering Journal, 2021, 421: 127808.

（7）X. Wang, B. Gao, Y. Feng^*, Recent advances in inhibiting atherosclerosis and restenosis: from pathogenic factors, therapeutic molecules to nano-delivery strategies. Journal of Materials Chemistry B, 2022, 10(11): 1685-1708.

（8）X. Wang^#, B. Su^#, B. Gao^#, J. Zhou, X.-k. Ren, J. Guo, S. Xia, W. Zhang, Y. Feng^*, Cascaded bio-responsive delivery of eNOS gene and ZNF580 gene to collaboratively treat hindlimb ischemia via pro-angiogenesis and anti-inflammation. Biomaterials Science, 2020, 8(23): 6545-6560.

（9）X. Wang^#, B. Gao^#, X.-K. Ren, J. Guo, S. Xia, W. Zhang, C. Yang^*, Y. Feng^*, A two-pronged approach to regulate the behaviors of ECs and SMCs by the dual targeting-nanoparticles. Colloids and Surfaces, B: Biointerfaces, 2021, 208, 112068.

（10）B. Gao^#, X. Wang^#, M. Wang, W. Liu, Y. Li, S. Xia, W. Zhang, Y. Feng^*, Intercellular-Mass-Transport Mimic Enables ASO Completely into Cell Nucleus for Enhanced Ischemia Therapy. ACS Applied Materials & Interfaces, 2023, 15, 12777−12786.